Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...

Primary effectiveness was measured by the number of patients with HIV-1 RNA ≥50 copies/mL at Week 48, as well as the number of patients with a change in CD4 cell count, and the proportion of patients ...

Congress's bipartisan agreement to end the government shutdown restores operations across the federal government, but keeps ...

APPLIN: After nearly 20 years in HIV care, I’ve seen that HIV follows people through every season of life. When life is stable, patients stay in care and maintain suppression, but when challenges ...

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...

The two-drug regimen dolutegravir/lamivudine is as effective as the three-drug regimen dolutegravir plus tenofovir ...

Keeping up with HIV treatment isn’t always easy. Anyone can face setbacks along the way. Staying on top of doctor’s appointments and taking medications regularly can feel overwhelming to manage ...

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...

Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...

Understanding the benefits of early treatment for HIV is crucial for managing the disease effectively. Starting treatment soon after diagnosis not only preserves health but also enhances the quality ...

Interestingly, and nauseatingly, the president’s first administration was pretty good on HIV research and prevention. Things ...

A tailored approach with rapid needs assessment before and during implementation to address local testing site barriers in ...